GYLDEN LIMITED

Active Abingdon

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
G

GYLDEN LIMITED

Research and experimental development on biotechnology

Founded 20 Apr 2023 Active Abingdon, United Kingdom 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 26 Nov 2024 Next due 31 Dec 2025 6 months overdue
Confirmation Submitted 9 Jul 2025 Next due 3 May 2026 2 months overdue
Net assets £1
Total assets £1
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

4&5 Dunmore Court Wootton Road Abingdon Oxfordshire OX13 6BH United Kingdom

Full company profile for GYLDEN LIMITED (14818028), an active company based in Abingdon, United Kingdom. Incorporated 20 Apr 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2024
Type dormant
Next accounts 31 Mar 2025
Due by 31 Dec 2025 6 months overdue

Net Assets, Total Assets & Total Liabilities (2023–2023)

Cash in Bank

N/A

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Mar Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active
Status
Moore-thornicroft, Storme Jo-anneDirectorBritishUnited Kingdom5220 Apr 2023Active

Shareholders

Shareholders (1)

Gylden Pharma Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 20 Apr 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GYLDEN PHARMA LIMITED united kingdom
GYLDEN LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 May 2026GazetteGazette Dissolved Compulsory
3 Mar 2026GazetteGazette Notice Compulsory
12 Jul 2025GazetteGazette Filings Brought Up To Date
9 Jul 2025Confirmation StatementConfirmation statement made on 19 Apr 2025 with no updates
8 Jul 2025GazetteGazette Notice Compulsory
19 May 2026 Gazette

Gazette Dissolved Compulsory

3 Mar 2026 Gazette

Gazette Notice Compulsory

12 Jul 2025 Gazette

Gazette Filings Brought Up To Date

9 Jul 2025 Confirmation Statement

Confirmation statement made on 19 Apr 2025 with no updates

8 Jul 2025 Gazette

Gazette Notice Compulsory

Recent Activity

Latest Activity

Gazette Dissolved Compulsory

2 weeks ago on 19 May 2026

Gazette Notice Compulsory

3 months ago on 3 Mar 2026

Gazette Filings Brought Up To Date

10 months ago on 12 Jul 2025

Confirmation statement made on 19 Apr 2025 with no updates

11 months ago on 9 Jul 2025

Gazette Notice Compulsory

11 months ago on 8 Jul 2025